Silymarin NEW
| Price | $62 |
| Package | 500mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-05-26 |
Product Details
| Product Name: Silymarin | CAS No.: 65666-07-1 |
| Supply Ability: 10g | Release date: 2025/05/26 |
Product Introduction
Bioactivity
| Name | Silymarin |
| Description | Silymarin (Silybin B) (Silybin B) is a polyphenolic flavonoid that extracts from the milk thistle or seeds of Silybum marianum. It is used in the prevention and treatment of liver diseases. |
| In vitro | Mechanism of Silymarin involves different biochemical reactions, such as stimulation of the rate of ribosomal RNA synthesis by stimulating the transcription of polymerase I and ribosomal RNA genes, blockage of alpha-glycoside loops toxin intake, and protection of cell membranes from free radical-induced damage. Silymarin also displays a substantial protective effect against UVB-induced canceration at different stages, possibly through its strong antioxidant properties. |
| In vivo | The intravenous injection LD50 of Silymarin is 391.4 mg/kg, 70.1 mg/kg, 142.3 mg/kg for mice, rats, rabbits, respectively. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 45 mg/mL (93.28 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : 1 mg/mL (2.07 mM), Sonication is recommended. |
| Keywords | thistle | Silymarin | SARS-CoV | SARSCoV | SARS coronavirus | resistance | proliferation | Milk | insulin | Inhibitor | inhibit | hepatocellular | HCC | chemopreventive | carcinoma | angiogenesis |
| Inhibitors Related | Nirmatrelvir | EIDD-1931 | Remdesivir | Andrographolide | Molnupiravir | Umifenovir hydrochloride | Hydroxychloroquine | Ritonavir | Chloroquine phosphate | Dexamethasone | Favipiravir | Bromhexine hydrochloride |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Flavonoid Natural Product Library | Traditional Chinese Medicine Monomer Library | Bioactive Compound Library | Selected Plant-Sourced Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Natural Product Library | Anti-Viral Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Heat-Clearing and Detoxifying Traditional Chinese Medicine Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00/1g |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-06-02 | |
| $0.00/5kg |
VIP3Y
|
Hebei ZB Gamay Biological Technology Co.,Ltd
|
2025-05-12 | |
| $5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-08 | |
| $0.00/1kg |
VIP1Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-27 | |
| $0.00/1kg |
VIP1Y
|
Chongqing Soarwin Technology Co., Ltd
|
2025-04-11 | |
| $150.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-10 | |
| $10.00/1kg |
VIP1Y
|
Aurora Industry Co., Ltd.
|
2024-09-09 | |
| $0.10/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2024-07-06 | |
| $0.00/25kg |
VIP2Y
|
BINBO BIOLOGICAL CO.,LTD
|
2024-04-22 | |
| $0.00/1KG |
VIP4Y
|
ZhenYiBio Technology Inc
|
2024-03-26 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY